SEVERE ASTHMA
Clinical trials for SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart inhalers track Fasenra's asthma control over full dosing cycle
Disease control Not yet recruitingThis study tracks people with severe eosinophilic asthma who already take Fasenra (benralizumab) every 8 weeks. Participants use electronic monitors on their regular inhalers and a study-provided rescue inhaler (AirSupra) to see if asthma control stays steady throughout the dosin…
Matched conditions: SEVERE ASTHMA
Phase: PHASE4 • Sponsor: Endeavor Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study monitors Real-World safety of asthma drug tezepelumab in korea
Disease control Not yet recruitingThis study observes 210 patients in South Korea who are prescribed Tezepelumab for severe asthma or chronic sinusitis with nasal polyps. Researchers will track side effects and how well the drug controls symptoms in everyday use. The goal is to confirm the drug's safety and effec…
Matched conditions: SEVERE ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New monthly shot could keep severe asthma patients out of the ER
Disease control Not yet recruitingThis study tests whether a monthly injection called Tezepelumab can help adults with severe asthma avoid repeated emergency room visits and asthma attacks. One hundred participants will receive either the drug or a placebo for 90 days, followed by an open-label extension. The goa…
Matched conditions: SEVERE ASTHMA
Phase: PHASE4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill could help severe asthma sufferers breathe easier
Disease control Not yet recruitingThis study tests a new drug called frevecitinib (KN-002) in 512 adults with severe asthma that is not well controlled by their current treatments. Participants will take one of three doses of the drug or a placebo daily for 12 weeks. The main goal is to see if the drug improves l…
Matched conditions: SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Kinaset Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Hope for severe asthma: study tests if biologics can heal lungs
Knowledge-focused Not yet recruitingThis study looks at whether biologic therapy can reverse long-term lung damage in adults with severe asthma. Researchers will follow 150 patients and 50 healthy volunteers for two years, using advanced imaging and lung function tests. The goal is to see if treatment leads to 'cli…
Matched conditions: SEVERE ASTHMA
Phase: NA • Sponsor: Western University, Canada • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:58 UTC